🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are inviting applications for postdoc and graduate student positions, as detailed below. Please share if you know someone who may be interested! sites.google.com/ualberta.ca/yo…

It is always difficult to select the most optimal ASO sequence for splice modulation of transcripts. Toshifumi Yokota will present the e-skip-Finder, a freely available tool to select the best ASO for your studies. #ASO2022 Oligonucleotide Therapeutics Society

Exciting news! A new book, 'Muscular Dystrophy Therapeutics' has just been released, providing in-depth information on the latest methods to develop therapies for this debilitating condition. #musculardystrophy #therapeutics Springer Nature link.springer.com/book/10.1007/9…

Published! Congratulations, Tejal! TEJAL ASLESH JCI Insight - DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration insight.jci.org/articles/view/…

Thrilled to share our latest findings on the potential of DG9-conjugated morpholino as a treatment for spinal muscular atrophy! Our study shows significant improvements in survival, SMN expression, and muscle function in a mouse model. UAlberta Med & Dent insight.jci.org/articles/view/…

We couldn't have done it without the support of our funding partners! Our study was made possible by the Friends of Garrett Cumming Research & Muscular Dystrophy Canada Research Chair Fund, Women & Children's Health Research Institute, CIHR-IHDCYH. Their support allows us to work towards finding innovative solutions for #SMA.

DG9-conjugated morpholino rescues phenotype in SMA mice by reaching the CNS via a subcutaneous administration: buff.ly/42bjfeq Prof. Toshi Yokota PhD FCAHS @MD_Canada Res Chair Rika Maruyama, Ph.D. University of Alberta #Genetics #MuscleBiology

Thrilled to share that my PhD student Ahad is presenting his cutting-edge research at #MDAConference! Discover how exon 44 skipping using DG9-PMO restores dystrophin, enhances function and offers cardiac protection in DMD model mice🐁🧬. Don't miss it! 🔗 mdaconference.org/abstract-libra…

📸 Just took a new lab group picture after three years! So proud of our team and it's incredible to see how much we've grown and accomplished together. Here's to many more years of collaboration and scientific discoveries! 🧪🔬 #LabLife #TeamWork #Science #Research

Deeply honoured that OligomicsTx has received the Spin-Off Award from the University of Alberta! Huge thanks to our passionate team and all our supporters. Exciting news: Our website is on its way!🚀 #OligomicsTx #UniversityOfAlberta #RNAtherapy

Thrilled to share that #OligomicsTx has won $50,000 at the Startup TNT Summit Finale! 🌟 A huge thank you to the angel investors and everyone involved. Excited for the next steps in developing RNA-targeting therapies for rare neuromuscular disorders. edmonton.taproot.news/briefs/2024/03…

🚨 Exciting Opportunity! Join our team at the University of Alberta as a Postdoctoral Fellow! We're seeking innovative thinkers to explore treatments for muscular dystrophy & rare diseases using advanced techniques like CRISPR & ASOs. Please RT! jrecin.jst.go.jp/seek/SeekJorDe…

Excited to share that OligomicsTx has been awarded funding from the Edmonton Edge Fund! This support will accelerate our development of pioneering treatment for Muscular Dystrophy. Thanks to the City of Edmonton, we can push the boundaries of innovation. edmonton.taproot.news/briefs/2024/05…

Excited to share that a PhD student from our lab Saeed has won the Outstanding Poster Award at #ASGCT2024 for his work on enhancing antisense oligonucleotide efficacy with small molecule OAEs! Congratulations Saeed on this well-deserved recognition! 🎉👏 UAlberta Med & Dent Women & Children's Health Research Institute

Thank you for supporting OligomicsTx !!!

Thrilled to unveil our new #YokotaLab T-shirt designed by talented Saeed, a brilliant student in our team! 📷 This design beautifully captures the essence of our work in genetic medicine. Proud of the creativity and collaboration in our lab! #TeamWork #ScienceFashion

Exciting opportunities available at my lab UAlberta Med & Dent! We are hiring postdocs, as well as grad students, to join our cutting-edge research team. If you’re passionate about advancing treatments for muscular dystrophy and genetic diseases, apply now! 👉 linkedin.com/jobs/view/3443…

Excited to share the launch of the new OligomicsTx website! Check out our latest innovations in RNA therapeutics for neuromuscular diseases and stay updated on our research. Visit us at oligomicstx.com. #RNAtherapeutics #NeuromuscularDiseases #Biotech OligomicsTx

The halt has frozen research grants, meetings and key health updates. “Everything is basically in chaos,” said one cancer researcher. wapo.st/4htuENu

Excited to share our latest study in Nucleic Acids Research! AOC 1044 successfully induces exon 44 skipping and restores dystrophin in preclinical DMD models—including heart tissue. Proud to collaborate with @AvidityBio! academic.oup.com/nar/article/53… UAlberta Med & Dent